NEW YORK (GenomeWeb News) – For the second quarter ended June 30, Genomic Health reported revenues of $63.7 million, compared to $57.6 million during the same period last year, marking an 11 percent increase.

However, the firm fell short of Wall Street's estimates for the top and bottom line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.